Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Xywav
DRUG
2 trials
Sponsors
Leiden University Medical Center
, Jazz Pharmaceuticals
Conditions
Cerebral Amyloid Angiopathy
Idiopathic Hypersomnia
Narcolepsy
Phase 2
Stimulating Amyloid Clearance in Cerebral Amyloid Angiopathy
Enrolling by invitation
NCT06421532
Leiden University Medical Center
Cerebral Amyloid Angiopathy
Start: 2025-03-27
End: 2027-09-27
Target: 60
Updated: 2026-02-24
Phase 3
A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH
Recruiting
NCT07625280
Jazz Pharmaceuticals
Idiopathic Hypersomnia, Narcolepsy
Start: 2026-07-09
End: 2028-01-06
Target: 120
Updated: 2026-08-19
Related Papers
Stimulating amyloid-β clearance in cerebral amyloid angiopathy with low-sodium oxybate and/or non-invasive vagus nerve stimulation (Clear-Brain): study protocol for a randomised pre-post trial.
2026-03-11